中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/12/02 | 6,574 | 6,654 | 6,490 | 6,605 | +7 | +0.1% | 1,490,000 |
| 2024/11/29 | 6,614 | 6,654 | 6,483 | 6,598 | -14 | -0.2% | 1,722,200 |
| 2024/11/28 | 6,594 | 6,715 | 6,570 | 6,612 | +36 | +0.5% | 1,845,700 |
| 2024/11/27 | 6,449 | 6,654 | 6,390 | 6,576 | +201 | +3.2% | 2,640,000 |
| 2024/11/26 | 6,397 | 6,429 | 6,315 | 6,375 | -122 | -1.9% | 1,713,800 |
| 2024/11/25 | 6,310 | 6,518 | 6,286 | 6,497 | +227 | +3.6% | 3,842,600 |
| 2024/11/22 | 6,348 | 6,389 | 6,270 | 6,270 | -113 | -1.8% | 2,466,200 |
| 2024/11/21 | 6,427 | 6,510 | 6,370 | 6,383 | -1 | ±0% | 1,627,200 |
| 2024/11/20 | 6,544 | 6,556 | 6,331 | 6,384 | -60 | -0.9% | 2,286,100 |
| 2024/11/19 | 6,491 | 6,499 | 6,345 | 6,444 | +17 | +0.3% | 3,211,200 |
| 2024/11/18 | 6,900 | 6,906 | 6,427 | 6,427 | -714 | -10% | 3,914,100 |
| 2024/11/15 | 7,268 | 7,349 | 7,141 | 7,141 | +11 | +0.2% | 1,687,800 |
| 2024/11/14 | 7,204 | 7,303 | 7,127 | 7,130 | +1 | ±0% | 1,395,500 |
| 2024/11/13 | 7,236 | 7,245 | 7,108 | 7,129 | -187 | -2.6% | 1,921,900 |
| 2024/11/12 | 7,426 | 7,476 | 7,273 | 7,316 | -109 | -1.5% | 1,886,300 |
| 2024/11/11 | 7,267 | 7,429 | 7,254 | 7,425 | +185 | +2.6% | 1,304,400 |
| 2024/11/08 | 7,252 | 7,290 | 7,176 | 7,240 | +194 | +2.8% | 2,377,200 |
| 2024/11/07 | 7,079 | 7,191 | 6,941 | 7,046 | -183 | -2.5% | 2,802,600 |
| 2024/11/06 | 7,085 | 7,229 | 6,945 | 7,229 | +144 | +2% | 2,611,000 |
| 2024/11/05 | 7,150 | 7,188 | 7,016 | 7,085 | -128 | -1.8% | 2,596,600 |
| 2024/11/01 | 7,190 | 7,310 | 7,155 | 7,213 | -127 | -1.7% | 1,936,500 |
| 2024/10/31 | 7,357 | 7,401 | 7,276 | 7,340 | ±0 | ±0% | 2,714,300 |
| 2024/10/30 | 7,510 | 7,568 | 7,340 | 7,340 | -378 | -4.9% | 4,797,400 |
| 2024/10/29 | 7,778 | 7,828 | 7,643 | 7,718 | -137 | -1.7% | 2,964,800 |
| 2024/10/28 | 7,280 | 7,869 | 7,275 | 7,855 | +986 | +14.4% | 6,574,000 |
| 2024/10/25 | 6,870 | 6,880 | 6,770 | 6,869 | -73 | -1.1% | 1,295,500 |
| 2024/10/24 | 6,912 | 7,053 | 6,828 | 6,942 | +52 | +0.8% | 1,993,300 |
| 2024/10/23 | 6,884 | 6,970 | 6,825 | 6,890 | +5 | +0.1% | 1,740,700 |
| 2024/10/22 | 7,000 | 7,035 | 6,873 | 6,885 | -118 | -1.7% | 1,554,000 |
| 2024/10/21 | 7,010 | 7,059 | 6,921 | 7,003 | -19 | -0.3% | 1,122,900 |
| 2024/10/18 | 7,104 | 7,141 | 6,981 | 7,022 | -20 | -0.3% | 1,176,800 |
| 2024/10/17 | 7,231 | 7,231 | 7,038 | 7,042 | -119 | -1.7% | 2,014,900 |
| 2024/10/16 | 7,342 | 7,371 | 7,159 | 7,161 | -296 | -4% | 2,633,800 |
| 2024/10/15 | 7,446 | 7,652 | 7,428 | 7,457 | +352 | +5% | 3,600,800 |
| 2024/10/11 | 7,049 | 7,192 | 7,028 | 7,105 | +156 | +2.2% | 2,882,800 |
| 2024/10/10 | 7,028 | 7,065 | 6,931 | 6,949 | -79 | -1.1% | 1,321,600 |
| 2024/10/09 | 6,985 | 7,043 | 6,943 | 7,028 | +133 | +1.9% | 1,165,300 |
| 2024/10/08 | 6,808 | 6,897 | 6,784 | 6,895 | -13 | -0.2% | 2,018,400 |
| 2024/10/07 | 6,961 | 7,055 | 6,854 | 6,908 | -7 | -0.1% | 2,378,600 |
| 2024/10/04 | 6,900 | 7,068 | 6,897 | 6,915 | -65 | -0.9% | 1,752,700 |
| 2024/10/03 | 7,051 | 7,078 | 6,932 | 6,980 | +129 | +1.9% | 1,609,700 |
| 2024/10/02 | 7,052 | 7,085 | 6,771 | 6,851 | -223 | -3.2% | 2,730,200 |
| 2024/10/01 | 6,970 | 7,116 | 6,941 | 7,074 | +142 | +2% | 1,803,200 |
| 2024/09/30 | 6,889 | 7,056 | 6,880 | 6,932 | -407 | -5.5% | 3,733,200 |
| 2024/09/27 | 7,212 | 7,339 | 7,097 | 7,339 | +197 | +2.8% | 2,794,500 |
| 2024/09/26 | 6,965 | 7,177 | 6,862 | 7,142 | +142 | +2% | 3,812,200 |
| 2024/09/25 | 7,125 | 7,248 | 6,950 | 7,000 | -96 | -1.4% | 2,362,600 |
| 2024/09/24 | 6,884 | 7,100 | 6,866 | 7,096 | +247 | +3.6% | 3,119,700 |
| 2024/09/20 | 6,888 | 6,946 | 6,849 | 6,849 | +41 | +0.6% | 2,275,900 |
| 2024/09/19 | 6,879 | 6,911 | 6,782 | 6,808 | +54 | +0.8% | 1,715,000 |
101～
150
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
